NCM
ABBV icon

Narwhal Capital Management’s AbbVie ABBV Stock Holding History

Narwhal Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-19,750
Closed -$1.01M – 140
2014
Q1 		$1.01M Hold
19,750
– – 0.42% 84
2013
Q4 		$1.04M Sell
19,750
-550
-3% -$27K 0.43% 84
2013
Q3 		$908K Buy
20,300
+1,050
+5% +$46.5K 0.43% 90
2013
Q2 		$796K Buy
+19,250
New +$842K 0.38% 94

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Narwhal Capital Management's ABBV Position: Q2 2014 in Review

Narwhal Capital Management sold out of AbbVie (ABBV) in Q2 2014, closing a stake of 19,750 shares — an estimated $1.01M sold.

Narwhal Capital Management first reported a position in ABBV in Q2 2013 and held it in 4 quarters. The position peaked at $1.04M in Q4 2013. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

  • Narwhal Capital Management reported no remaining AbbVie position as of Q2 2014 after selling out during the quarter.
  • Narwhal Capital Management sold 19,750 AbbVie shares in Q2 2014, an estimated $1.01M.
  • Narwhal Capital Management first reported a position in AbbVie in Q2 2013 and held it in 4 quarters.
  • Narwhal Capital Management's AbbVie position peaked at $1.04M in Q4 2013.
  • 1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Narwhal Capital Management's 13F filing for Q2 2014, filed 29 Jul 2014.